111 related articles for article (PubMed ID: 9792236)
1. Expression of FAC1 in activated microglia during Alzheimer's disease.
Bowser R; Reilly S
Neurosci Lett; 1998 Sep; 253(3):163-6. PubMed ID: 9792236
[TBL] [Abstract][Full Text] [Related]
2. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
[TBL] [Abstract][Full Text] [Related]
3. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
[TBL] [Abstract][Full Text] [Related]
4. The presence of FAC1 protein in Hirano bodies.
Jordan-Sciutto K; Dragich J; Walcott D; Bowser R
Neuropathol Appl Neurobiol; 1998 Oct; 24(5):359-66. PubMed ID: 9821166
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease.
Schoonover S; Davies P; Bowser R
J Neuropathol Exp Neurol; 1996 Apr; 55(4):444-55. PubMed ID: 8786404
[TBL] [Abstract][Full Text] [Related]
6. Acidic FGF expression in the surroundings of senile plaques.
Kimura H; Tooyama I; McGeer PL
Tohoku J Exp Med; 1994 Nov; 174(3):279-93. PubMed ID: 7539161
[TBL] [Abstract][Full Text] [Related]
7. Fluoro-Jade B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease.
Damjanac M; Rioux Bilan A; Barrier L; Pontcharraud R; Anne C; Hugon J; Page G
Brain Res; 2007 Jan; 1128(1):40-9. PubMed ID: 17125750
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes and the plaques of Alzheimer's disease.
Mandybur TI; Chuirazzi CC
Neurology; 1990 Apr; 40(4):635-9. PubMed ID: 1690867
[TBL] [Abstract][Full Text] [Related]
9. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology.
Hendrickx DAE; van Eden CG; Schuurman KG; Hamann J; Huitinga I
J Neuroimmunol; 2017 Aug; 309():12-22. PubMed ID: 28601280
[TBL] [Abstract][Full Text] [Related]
10. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction.
Orre M; Kamphuis W; Osborn LM; Jansen AHP; Kooijman L; Bossers K; Hol EM
Neurobiol Aging; 2014 Dec; 35(12):2746-2760. PubMed ID: 25002035
[TBL] [Abstract][Full Text] [Related]
11. Regression stage senile plaques in the natural course of Alzheimer's disease.
Oide T; Kinoshita T; Arima K
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888
[TBL] [Abstract][Full Text] [Related]
12. Expression of alpha B-crystallin in Alzheimer's disease.
Renkawek K; Voorter CE; Bosman GJ; van Workum FP; de Jong WW
Acta Neuropathol; 1994; 87(2):155-60. PubMed ID: 8171966
[TBL] [Abstract][Full Text] [Related]
13. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics.
Radewicz K; Garey LJ; Gentleman SM; Reynolds R
J Neuropathol Exp Neurol; 2000 Feb; 59(2):137-50. PubMed ID: 10749103
[TBL] [Abstract][Full Text] [Related]
14. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.
Nagele RG; Wegiel J; Venkataraman V; Imaki H; Wang KC; Wegiel J
Neurobiol Aging; 2004; 25(5):663-74. PubMed ID: 15172746
[TBL] [Abstract][Full Text] [Related]
15. Digoxigenin-tagged anti-GFAP and multiple labelling of human glia, vessels and beta-amyloid.
Härtig W; Hausen D; Brauer K; Arendt T; Bigl V; Brückner G
Neuroreport; 1994 Jan; 5(5):573-6. PubMed ID: 8025246
[TBL] [Abstract][Full Text] [Related]
16. Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity.
Jordan-Sciutto KL; Dragich JM; Caltagarone J; Hall DJ; Bowser R
Biochemistry; 2000 Mar; 39(12):3206-15. PubMed ID: 10727212
[TBL] [Abstract][Full Text] [Related]
17. A possible model of senile plaques using synthetic amyloid beta-protein and rat glial culture.
Isobe I; Yanagisawa K; Michikawa M
Exp Neurol; 2000 Mar; 162(1):51-60. PubMed ID: 10716888
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
[TBL] [Abstract][Full Text] [Related]
20. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model.
Kamphuis W; Orre M; Kooijman L; Dahmen M; Hol EM
Glia; 2012 Apr; 60(4):615-29. PubMed ID: 22262260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
